Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study.

[1]  A. Czeizel,et al.  The role of pharmacoepidemiology in pharmacovigilance: rational drug use in pregnancy , 1999, Pharmacoepidemiology and drug safety.

[2]  J. Olsen,et al.  Use of antibiotics during pregnancy. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[3]  A. Czeizel.  First 25 years of the Hungarian congenital abnormality registry. , 1997, Teratology.

[4]  A. L. Short.  The effects of drugs on the fetus and nursing infant , 1996 .

[5]  G. Wendel,et al.  Treatment of gonorrhea in pregnancy , 1993, Obstetrics and gynecology.

[6]  A. Czeizel,et al.  Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies. , 1990, Teratology.

[7]  G. Greenberg,et al.  Drugs in Pregnancy and Lactation , 1990 .

[8]  Gábor Tusnády,et al.  Multiple congenital abnormalities , 1988 .

[9]  A. Bint,et al.  Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy , 1985, Antimicrobial Agents and Chemotherapy.

[10]  P. A. James,et al.  BRL25000の生殖試験 (第4報):ブタにおける器官形成期投与試験 , 1983 .

[11]  高瀬 善次郎,et al.  産婦人科領域におけるBRL25000 (Clavulanic acid-Amoxicillin) の基礎的・臨床的検討 , 1982 .

[12]  O. Jordheim,et al.  Study of ampicillin levels in maternal serum, umbilical cord serum and amniotic fluid following administration of pivampicillin , 1980, Acta obstetricia et gynecologica Scandinavica.

[13]  T. Shepard.  Catalog of Teratogenic Agents , 1973 .

[14]  W. L. Johnson,et al.  Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy. , 1966, American journal of obstetrics and gynecology.

[15]  M. MacAulay,et al.  Placental transfer of ampicillin. , 1966, American journal of obstetrics and gynecology.